Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2022 Jan 28;74(3):371–376. doi: 10.1002/acr.24496

Table 1:

Characteristics of patients with sarcoidosis in the RISE registry.

Characteristics
mean±SD / N (%)
Total patients
(N=3276)
Age 59.1 ± 12.5
Sex Female 2461 75.1%
Race White 1582 48.3%
Black or African American 905 27.6%
Other* 789 24.1%
Insurance Medicare 803 24.5%
Medicaid 115 3.5%
Private 1205 36.7%
Other§ 151 4.6%
Missing 1002 30.6%
U.S. Geographic Division East North Central 107 3.3%
West North Central 510 15.6%
Mid-Atlantic 384 11.7%
Mountain 299 9.1%
New England 874 26.7%
Pacific 396 12.1%
South Atlantic 321 9.8%
East South Central 69 2.1%
West South Central 316 9.6%
Practice type Single specialty group 2205 67.3%
Multi-specialty group 555 16.9%
Solo practitioner 289 8.8%
Other clinical setting 186 5.7%
Health system 41 1.2%
Comorbidities Charlson Score; mean±SD 1.3 ± 0.9
Hypertension (y/n) 545 16.6%
Asthma (y/n) 189 5.8%
Diabetes (y/n) 321 9.8%
Cancer (y/n) 177 5.4%
Number of visits in RISE; median (IQR) 3.5 (2–6.5)
Duration of follow up time (years); median (IQR) 1.9 (0.6–4.2)

Abbreviations: SD: standard deviation, IQR: interquartile range,

*

Other race included Hispanic or Latino, Asian, Native Hawaiian or other Pacific Island, American Indian or Alaska Native, and multi-racial,

§

Other insurance included veterans and other.